Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,941 | -11,969 | -7,630 |
| Depreciation Amortization | 16 | 0 | 0 |
| Accounts receivable | 919 | N/A | N/A |
| Other Working Capital | 1,123 | 1,404 | -611 |
| Other Operating Activity | -791 | 39 | 39 |
| Operating Cash Flow | $-2,674 | $-10,526 | $-8,202 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -29 | 0 | 0 |
| Investing Cash Flow | $-29 | $0 | $0 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 3 | N/A | N/A |
| Other Financing Activity | -16 | 79,980 | 15,201 |
| Financing Cash Flow | $-13 | $79,980 | $15,201 |
| Beginning Cash Position | 76,453 | 6,999 | 0 |
| End Cash Position | 73,737 | 76,453 | 6,999 |
| Net Cash Flow | $-2,716 | $69,454 | $6,999 |
| Free Cash Flow | |||
| Operating Cash Flow | -2,674 | -10,526 | -8,202 |
| Capital Expenditure | -29 | N/A | N/A |
| Free Cash Flow | -2,703 | -10,526 | -8,202 |